Yasuhisa Fujii

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide, a calmodulin antagonist, inhibits cell proliferation.

Hisashi Hidaka, Yasuharu Sasaki, Toshio Tanaka et al. · Proceedings of the National Academy of Sciences · 1981 · 584 citations · Full text

Chemoprevention Strategy, Cell Death, Cellular Pharmacology +17

Adult Xp11 Translocation Renal Cell Carcinoma Diagnosed by Cytogenetics and Immunohistochemistry

Yoshinobu Komai, Mutsunori Fujiwara, Yasuhisa Fujii et al. · Clinical Cancer Research · 2009 · 234 citations

The G/G Genotype of a Resistin Single-Nucleotide Polymorphism at −420 Increases Type 2 Diabetes Mellitus Susceptibility by Inducing Promoter Activity through Specific Binding of Sp1/3

Haruhiko Osawa, Kazuya Yamada, Hiroshi Onuma et al. · The American Journal of Human Genetics · 2004 · 233 citations · Full text

Resistin Single-nucleotide Polymorphism, Metabolic Syndrome, Genetic Determinant +11

Distilling Step-by-Step! Outperforming Larger Language Models with Less Training Data and Smaller Model Sizes

Cheng-Yu Hsieh, Chunliang Li, Chih‐Kuan Yeh et al. · 2023 · 210 citations · Full text

Llm Fine-tuning, Engineering, Machine Learning +23